Skip to main content
رجوع
Watch Compare

Polomar Health Services, Inc.

جودة البيانات: 100%
PMHS
OTC Manufacturing Chemicals
KWD 0.16
KWD 0.00 (0.00%)
القيمة السوقية: 4.49 M
السعر
KWD 0.16
القيمة السوقية
4.49 M
نطاق اليوم
KWD 0.08 — KWD 0.08
نطاق 52 أسبوعًا
KWD 0.07 — KWD 0.80
حجم التداول
1
فتح KWD 0.08
متوسط 50 يوم / 200 يوم
KWD 0.28
41.86% below
متوسط 50 يوم / 200 يوم
KWD 0.30
46.97% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -991,904.0
Capital intensive — 245.36% of revenue goes to capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)70.38%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-30.08%
أعلى من متوسط القطاع (-51.02%)
ROIC-22.45%
Net Margin-6562.42%
Op. Margin-6199.82%

الأمان

Debt / Equity
N/A
Current Ratio0.13
Interest Coverage-17.10

التقييم

PE (TTM)
-1.85
أعلى من متوسط القطاع (-1.98)
P/B Ratio0.58
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -1.9 -2.0
P/B 0.6 5.1
ROE % -30.1 -51.0
Net Margin % -6562.4 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 70.38% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 37,044.0 Net Income (TTM) -2.43 M
ROE -30.08% ROA -26.00%
Gross Margin 55.09% Operating Margin -6199.82%
Net Margin -6562.42% Free Cash Flow (TTM) -991,904.0
ROIC -22.45% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.13
Interest Coverage -17.10 Asset Turnover 0.00
Working Capital -1.31 M Tangible Book Value 7.77 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.85 Forward P/E N/A
P/B Ratio 0.58 P/S Ratio 121.17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22.10%
Market Cap 4.49 M Enterprise Value 4.45 M
Per Share
EPS (Diluted TTM) -0.09 Revenue / Share 0.00
FCF / Share -0.04 OCF / Share -0.03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 245.36% FCF Conversion 40.80%
SBC-Adj. FCF -1.12 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023
Revenue 58,824.0 34,526.0
Net Income -1.34 M -416,500.0
EPS (Diluted) -0.05 -0.02
Gross Profit 30,903.0 34,526.0
Operating Income -1.30 M -269,830.0
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A 263,280.0 —
Interest Expense 41,837.0 —
Income Tax — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023
Total Assets 9.95 M 244.0
Total Liabilities 1.35 M 13,783.0
Shareholders' Equity 8.60 M -13,539.0
Total Debt — —
Cash & Equivalents 6,191.0 224.0
Current Assets 76,813.0 244.0
Current Liabilities 1.34 M 13,783.0